0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Abuse Screening Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-6P12882
Home | Market Reports | Health| Substance Abuse
Global Drug Abuse Screening Market Research Report 2022
BUY CHAPTERS

Global Drug Abuse Screening Market Research Report 2025

Code: QYRE-Auto-6P12882
Report
March 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug Abuse Screening Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Drug Abuse Screening Market

Drug Abuse Screening Market

The global market for Drug Abuse Screening was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Abuse Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Abuse Screening.
The Drug Abuse Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Abuse Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Abuse Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Drug Abuse Screening Market Report

Report Metric Details
Report Name Drug Abuse Screening Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Bio-Rad Laboratories, Clinical Reference Laboratory, Laboratory Corporation of America Holdings, Legacy Medical Services, LGC Group, Mayo Clinic Laboratories, Millennium Health, Omega Laboratories, Precision Diagnostics, Psychemedics, Quest Diagnostics, Sonic Healthcare, United States Drug Testing Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Drug Abuse Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Drug Abuse Screening Market report?

Ans: The main players in the Drug Abuse Screening Market are Abbott Laboratories, Bio-Rad Laboratories, Clinical Reference Laboratory, Laboratory Corporation of America Holdings, Legacy Medical Services, LGC Group, Mayo Clinic Laboratories, Millennium Health, Omega Laboratories, Precision Diagnostics, Psychemedics, Quest Diagnostics, Sonic Healthcare, United States Drug Testing Laboratories

What are the Application segmentation covered in the Drug Abuse Screening Market report?

Ans: The Applications covered in the Drug Abuse Screening Market report are Drug Testing Laboratories, Hospital, Others

What are the Type segmentation covered in the Drug Abuse Screening Market report?

Ans: The Types covered in the Drug Abuse Screening Market report are Urine Sample, Breath Sample, Oral Fluid Sample, Hair Sample

Recommended Reports

Drug Screening Testing

Diagnostic & Detection

Pharmaceutical Services

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Abuse Screening Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Urine Sample
1.2.3 Breath Sample
1.2.4 Oral Fluid Sample
1.2.5 Hair Sample
1.3 Market by Application
1.3.1 Global Drug Abuse Screening Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Testing Laboratories
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Abuse Screening Market Perspective (2020-2031)
2.2 Global Drug Abuse Screening Growth Trends by Region
2.2.1 Global Drug Abuse Screening Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Abuse Screening Historic Market Size by Region (2020-2025)
2.2.3 Drug Abuse Screening Forecasted Market Size by Region (2026-2031)
2.3 Drug Abuse Screening Market Dynamics
2.3.1 Drug Abuse Screening Industry Trends
2.3.2 Drug Abuse Screening Market Drivers
2.3.3 Drug Abuse Screening Market Challenges
2.3.4 Drug Abuse Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Abuse Screening Players by Revenue
3.1.1 Global Top Drug Abuse Screening Players by Revenue (2020-2025)
3.1.2 Global Drug Abuse Screening Revenue Market Share by Players (2020-2025)
3.2 Global Drug Abuse Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Abuse Screening Revenue
3.4 Global Drug Abuse Screening Market Concentration Ratio
3.4.1 Global Drug Abuse Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Abuse Screening Revenue in 2024
3.5 Global Key Players of Drug Abuse Screening Head office and Area Served
3.6 Global Key Players of Drug Abuse Screening, Product and Application
3.7 Global Key Players of Drug Abuse Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Abuse Screening Breakdown Data by Type
4.1 Global Drug Abuse Screening Historic Market Size by Type (2020-2025)
4.2 Global Drug Abuse Screening Forecasted Market Size by Type (2026-2031)
5 Drug Abuse Screening Breakdown Data by Application
5.1 Global Drug Abuse Screening Historic Market Size by Application (2020-2025)
5.2 Global Drug Abuse Screening Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Abuse Screening Market Size (2020-2031)
6.2 North America Drug Abuse Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Abuse Screening Market Size by Country (2020-2025)
6.4 North America Drug Abuse Screening Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Abuse Screening Market Size (2020-2031)
7.2 Europe Drug Abuse Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Abuse Screening Market Size by Country (2020-2025)
7.4 Europe Drug Abuse Screening Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Abuse Screening Market Size (2020-2031)
8.2 Asia-Pacific Drug Abuse Screening Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Abuse Screening Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Abuse Screening Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Abuse Screening Market Size (2020-2031)
9.2 Latin America Drug Abuse Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Abuse Screening Market Size by Country (2020-2025)
9.4 Latin America Drug Abuse Screening Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Abuse Screening Market Size (2020-2031)
10.2 Middle East & Africa Drug Abuse Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Abuse Screening Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Abuse Screening Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Drug Abuse Screening Introduction
11.1.4 Abbott Laboratories Revenue in Drug Abuse Screening Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Details
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Drug Abuse Screening Introduction
11.2.4 Bio-Rad Laboratories Revenue in Drug Abuse Screening Business (2020-2025)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Clinical Reference Laboratory
11.3.1 Clinical Reference Laboratory Company Details
11.3.2 Clinical Reference Laboratory Business Overview
11.3.3 Clinical Reference Laboratory Drug Abuse Screening Introduction
11.3.4 Clinical Reference Laboratory Revenue in Drug Abuse Screening Business (2020-2025)
11.3.5 Clinical Reference Laboratory Recent Development
11.4 Laboratory Corporation of America Holdings
11.4.1 Laboratory Corporation of America Holdings Company Details
11.4.2 Laboratory Corporation of America Holdings Business Overview
11.4.3 Laboratory Corporation of America Holdings Drug Abuse Screening Introduction
11.4.4 Laboratory Corporation of America Holdings Revenue in Drug Abuse Screening Business (2020-2025)
11.4.5 Laboratory Corporation of America Holdings Recent Development
11.5 Legacy Medical Services
11.5.1 Legacy Medical Services Company Details
11.5.2 Legacy Medical Services Business Overview
11.5.3 Legacy Medical Services Drug Abuse Screening Introduction
11.5.4 Legacy Medical Services Revenue in Drug Abuse Screening Business (2020-2025)
11.5.5 Legacy Medical Services Recent Development
11.6 LGC Group
11.6.1 LGC Group Company Details
11.6.2 LGC Group Business Overview
11.6.3 LGC Group Drug Abuse Screening Introduction
11.6.4 LGC Group Revenue in Drug Abuse Screening Business (2020-2025)
11.6.5 LGC Group Recent Development
11.7 Mayo Clinic Laboratories
11.7.1 Mayo Clinic Laboratories Company Details
11.7.2 Mayo Clinic Laboratories Business Overview
11.7.3 Mayo Clinic Laboratories Drug Abuse Screening Introduction
11.7.4 Mayo Clinic Laboratories Revenue in Drug Abuse Screening Business (2020-2025)
11.7.5 Mayo Clinic Laboratories Recent Development
11.8 Millennium Health
11.8.1 Millennium Health Company Details
11.8.2 Millennium Health Business Overview
11.8.3 Millennium Health Drug Abuse Screening Introduction
11.8.4 Millennium Health Revenue in Drug Abuse Screening Business (2020-2025)
11.8.5 Millennium Health Recent Development
11.9 Omega Laboratories
11.9.1 Omega Laboratories Company Details
11.9.2 Omega Laboratories Business Overview
11.9.3 Omega Laboratories Drug Abuse Screening Introduction
11.9.4 Omega Laboratories Revenue in Drug Abuse Screening Business (2020-2025)
11.9.5 Omega Laboratories Recent Development
11.10 Precision Diagnostics
11.10.1 Precision Diagnostics Company Details
11.10.2 Precision Diagnostics Business Overview
11.10.3 Precision Diagnostics Drug Abuse Screening Introduction
11.10.4 Precision Diagnostics Revenue in Drug Abuse Screening Business (2020-2025)
11.10.5 Precision Diagnostics Recent Development
11.11 Psychemedics
11.11.1 Psychemedics Company Details
11.11.2 Psychemedics Business Overview
11.11.3 Psychemedics Drug Abuse Screening Introduction
11.11.4 Psychemedics Revenue in Drug Abuse Screening Business (2020-2025)
11.11.5 Psychemedics Recent Development
11.12 Quest Diagnostics
11.12.1 Quest Diagnostics Company Details
11.12.2 Quest Diagnostics Business Overview
11.12.3 Quest Diagnostics Drug Abuse Screening Introduction
11.12.4 Quest Diagnostics Revenue in Drug Abuse Screening Business (2020-2025)
11.12.5 Quest Diagnostics Recent Development
11.13 Sonic Healthcare
11.13.1 Sonic Healthcare Company Details
11.13.2 Sonic Healthcare Business Overview
11.13.3 Sonic Healthcare Drug Abuse Screening Introduction
11.13.4 Sonic Healthcare Revenue in Drug Abuse Screening Business (2020-2025)
11.13.5 Sonic Healthcare Recent Development
11.14 United States Drug Testing Laboratories
11.14.1 United States Drug Testing Laboratories Company Details
11.14.2 United States Drug Testing Laboratories Business Overview
11.14.3 United States Drug Testing Laboratories Drug Abuse Screening Introduction
11.14.4 United States Drug Testing Laboratories Revenue in Drug Abuse Screening Business (2020-2025)
11.14.5 United States Drug Testing Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Drug Abuse Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Urine Sample
 Table 3. Key Players of Breath Sample
 Table 4. Key Players of Oral Fluid Sample
 Table 5. Key Players of Hair Sample
 Table 6. Global Drug Abuse Screening Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Drug Abuse Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Drug Abuse Screening Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Drug Abuse Screening Market Share by Region (2020-2025)
 Table 10. Global Drug Abuse Screening Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Drug Abuse Screening Market Share by Region (2026-2031)
 Table 12. Drug Abuse Screening Market Trends
 Table 13. Drug Abuse Screening Market Drivers
 Table 14. Drug Abuse Screening Market Challenges
 Table 15. Drug Abuse Screening Market Restraints
 Table 16. Global Drug Abuse Screening Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Drug Abuse Screening Market Share by Players (2020-2025)
 Table 18. Global Top Drug Abuse Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Abuse Screening as of 2024)
 Table 19. Ranking of Global Top Drug Abuse Screening Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Drug Abuse Screening Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Drug Abuse Screening, Headquarters and Area Served
 Table 22. Global Key Players of Drug Abuse Screening, Product and Application
 Table 23. Global Key Players of Drug Abuse Screening, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Drug Abuse Screening Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Drug Abuse Screening Revenue Market Share by Type (2020-2025)
 Table 27. Global Drug Abuse Screening Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Drug Abuse Screening Revenue Market Share by Type (2026-2031)
 Table 29. Global Drug Abuse Screening Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Drug Abuse Screening Revenue Market Share by Application (2020-2025)
 Table 31. Global Drug Abuse Screening Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Drug Abuse Screening Revenue Market Share by Application (2026-2031)
 Table 33. North America Drug Abuse Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Drug Abuse Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Drug Abuse Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Drug Abuse Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Drug Abuse Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Drug Abuse Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Drug Abuse Screening Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Drug Abuse Screening Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Drug Abuse Screening Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Drug Abuse Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Drug Abuse Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Drug Abuse Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Drug Abuse Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Drug Abuse Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Drug Abuse Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Abbott Laboratories Company Details
 Table 49. Abbott Laboratories Business Overview
 Table 50. Abbott Laboratories Drug Abuse Screening Product
 Table 51. Abbott Laboratories Revenue in Drug Abuse Screening Business (2020-2025) & (US$ Million)
 Table 52. Abbott Laboratories Recent Development
 Table 53. Bio-Rad Laboratories Company Details
 Table 54. Bio-Rad Laboratories Business Overview
 Table 55. Bio-Rad Laboratories Drug Abuse Screening Product
 Table 56. Bio-Rad Laboratories Revenue in Drug Abuse Screening Business (2020-2025) & (US$ Million)
 Table 57. Bio-Rad Laboratories Recent Development
 Table 58. Clinical Reference Laboratory Company Details
 Table 59. Clinical Reference Laboratory Business Overview
 Table 60. Clinical Reference Laboratory Drug Abuse Screening Product
 Table 61. Clinical Reference Laboratory Revenue in Drug Abuse Screening Business (2020-2025) & (US$ Million)
 Table 62. Clinical Reference Laboratory Recent Development
 Table 63. Laboratory Corporation of America Holdings Company Details
 Table 64. Laboratory Corporation of America Holdings Business Overview
 Table 65. Laboratory Corporation of America Holdings Drug Abuse Screening Product
 Table 66. Laboratory Corporation of America Holdings Revenue in Drug Abuse Screening Business (2020-2025) & (US$ Million)
 Table 67. Laboratory Corporation of America Holdings Recent Development
 Table 68. Legacy Medical Services Company Details
 Table 69. Legacy Medical Services Business Overview
 Table 70. Legacy Medical Services Drug Abuse Screening Product
 Table 71. Legacy Medical Services Revenue in Drug Abuse Screening Business (2020-2025) & (US$ Million)
 Table 72. Legacy Medical Services Recent Development
 Table 73. LGC Group Company Details
 Table 74. LGC Group Business Overview
 Table 75. LGC Group Drug Abuse Screening Product
 Table 76. LGC Group Revenue in Drug Abuse Screening Business (2020-2025) & (US$ Million)
 Table 77. LGC Group Recent Development
 Table 78. Mayo Clinic Laboratories Company Details
 Table 79. Mayo Clinic Laboratories Business Overview
 Table 80. Mayo Clinic Laboratories Drug Abuse Screening Product
 Table 81. Mayo Clinic Laboratories Revenue in Drug Abuse Screening Business (2020-2025) & (US$ Million)
 Table 82. Mayo Clinic Laboratories Recent Development
 Table 83. Millennium Health Company Details
 Table 84. Millennium Health Business Overview
 Table 85. Millennium Health Drug Abuse Screening Product
 Table 86. Millennium Health Revenue in Drug Abuse Screening Business (2020-2025) & (US$ Million)
 Table 87. Millennium Health Recent Development
 Table 88. Omega Laboratories Company Details
 Table 89. Omega Laboratories Business Overview
 Table 90. Omega Laboratories Drug Abuse Screening Product
 Table 91. Omega Laboratories Revenue in Drug Abuse Screening Business (2020-2025) & (US$ Million)
 Table 92. Omega Laboratories Recent Development
 Table 93. Precision Diagnostics Company Details
 Table 94. Precision Diagnostics Business Overview
 Table 95. Precision Diagnostics Drug Abuse Screening Product
 Table 96. Precision Diagnostics Revenue in Drug Abuse Screening Business (2020-2025) & (US$ Million)
 Table 97. Precision Diagnostics Recent Development
 Table 98. Psychemedics Company Details
 Table 99. Psychemedics Business Overview
 Table 100. Psychemedics Drug Abuse Screening Product
 Table 101. Psychemedics Revenue in Drug Abuse Screening Business (2020-2025) & (US$ Million)
 Table 102. Psychemedics Recent Development
 Table 103. Quest Diagnostics Company Details
 Table 104. Quest Diagnostics Business Overview
 Table 105. Quest Diagnostics Drug Abuse Screening Product
 Table 106. Quest Diagnostics Revenue in Drug Abuse Screening Business (2020-2025) & (US$ Million)
 Table 107. Quest Diagnostics Recent Development
 Table 108. Sonic Healthcare Company Details
 Table 109. Sonic Healthcare Business Overview
 Table 110. Sonic Healthcare Drug Abuse Screening Product
 Table 111. Sonic Healthcare Revenue in Drug Abuse Screening Business (2020-2025) & (US$ Million)
 Table 112. Sonic Healthcare Recent Development
 Table 113. United States Drug Testing Laboratories Company Details
 Table 114. United States Drug Testing Laboratories Business Overview
 Table 115. United States Drug Testing Laboratories Drug Abuse Screening Product
 Table 116. United States Drug Testing Laboratories Revenue in Drug Abuse Screening Business (2020-2025) & (US$ Million)
 Table 117. United States Drug Testing Laboratories Recent Development
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Drug Abuse Screening Picture
 Figure 2. Global Drug Abuse Screening Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drug Abuse Screening Market Share by Type: 2024 VS 2031
 Figure 4. Urine Sample Features
 Figure 5. Breath Sample Features
 Figure 6. Oral Fluid Sample Features
 Figure 7. Hair Sample Features
 Figure 8. Global Drug Abuse Screening Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Drug Abuse Screening Market Share by Application: 2024 VS 2031
 Figure 10. Drug Testing Laboratories Case Studies
 Figure 11. Hospital Case Studies
 Figure 12. Others Case Studies
 Figure 13. Drug Abuse Screening Report Years Considered
 Figure 14. Global Drug Abuse Screening Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Drug Abuse Screening Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Drug Abuse Screening Market Share by Region: 2024 VS 2031
 Figure 17. Global Drug Abuse Screening Market Share by Players in 2024
 Figure 18. Global Top Drug Abuse Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Abuse Screening as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Drug Abuse Screening Revenue in 2024
 Figure 20. North America Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Drug Abuse Screening Market Share by Country (2020-2031)
 Figure 22. United States Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Drug Abuse Screening Market Share by Country (2020-2031)
 Figure 26. Germany Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Drug Abuse Screening Market Share by Region (2020-2031)
 Figure 34. China Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Drug Abuse Screening Market Share by Country (2020-2031)
 Figure 42. Mexico Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Drug Abuse Screening Market Share by Country (2020-2031)
 Figure 46. Turkey Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Drug Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Abbott Laboratories Revenue Growth Rate in Drug Abuse Screening Business (2020-2025)
 Figure 50. Bio-Rad Laboratories Revenue Growth Rate in Drug Abuse Screening Business (2020-2025)
 Figure 51. Clinical Reference Laboratory Revenue Growth Rate in Drug Abuse Screening Business (2020-2025)
 Figure 52. Laboratory Corporation of America Holdings Revenue Growth Rate in Drug Abuse Screening Business (2020-2025)
 Figure 53. Legacy Medical Services Revenue Growth Rate in Drug Abuse Screening Business (2020-2025)
 Figure 54. LGC Group Revenue Growth Rate in Drug Abuse Screening Business (2020-2025)
 Figure 55. Mayo Clinic Laboratories Revenue Growth Rate in Drug Abuse Screening Business (2020-2025)
 Figure 56. Millennium Health Revenue Growth Rate in Drug Abuse Screening Business (2020-2025)
 Figure 57. Omega Laboratories Revenue Growth Rate in Drug Abuse Screening Business (2020-2025)
 Figure 58. Precision Diagnostics Revenue Growth Rate in Drug Abuse Screening Business (2020-2025)
 Figure 59. Psychemedics Revenue Growth Rate in Drug Abuse Screening Business (2020-2025)
 Figure 60. Quest Diagnostics Revenue Growth Rate in Drug Abuse Screening Business (2020-2025)
 Figure 61. Sonic Healthcare Revenue Growth Rate in Drug Abuse Screening Business (2020-2025)
 Figure 62. United States Drug Testing Laboratories Revenue Growth Rate in Drug Abuse Screening Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc